#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Duchenne muscular dystrophy Epileptic encephalopathy Mucous membrane pemphigoid Thromboangiitis obliterans Chronic myelomonocytic leukaemia Acute lymphocytic leukaemia Cardiac amyloidosis Metachromatic leukodystrophy ROHHAD syndrome Endometrial adenocarcinoma Biliary cancer metastatic Primitive neuroectodermal tumour Renal disorder Dedifferentiated liposarcoma X-linked lymphoproliferative syndrome More trials…

    Learn about Rare Diseases

    Sarcoidosis – Treatment Aicardi-Goutieres syndrome – Trials in Disease Thrombotic thrombocytopenic purpura – Basic Information Netherton’s syndrome – Treatment Soft tissue sarcoma – Life with Disease Chondrosarcoma – Basic Information Sarcoma – Basic Information Basal cell naevus syndrome – Basic Information Gastrointestinal stromal tumour – Life with Disease Primary hyperoxaluria – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Jnj-64042056 Folinic Acid Gemlapodect Ulotaront Seladelpar Ecoo25B Cendakimab Cx-037231 Daxdilimab Cx-039776 Pramipexole [18F] CANAGLIFLOZIN Cusatuzumab Diclofenac Deucrictibant LUNSEKIMIG Bupivacaine Hydrochloride 20-HYDROXYECDYSONE Busulfan TTX-381 More therapies…

    Learn about Your Condition

    Hypopituitarism Paget's disease of the vulva Guttate psoriasis Ocular melanoma Lumbosacral radiculopathy Scoliosis Tardive dyskinesia Otitis media Appendicitis perforated Vascular graft thrombosis Peritoneal neoplasm Albuminuria Infertility Pulmonary congestion Oropharyngeal cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Use of Metformin in Addition to Standard Treatment for Patients with Glioblastoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • Metformin Embonate
    Italy

  • Study on Cabozantinib and Nivolumab for Older Patients with Kidney Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Cabozantinib
    • Nivolumab
    France

  • Study on Reducing Acute Kidney Injury After Heart Surgery Using Angiotensin II or Noradrenaline for Patients with Low Blood Pressure

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • ANGIOTENSIN II
    • Noradrenaline Tartrate
    Germany

  • Study on the Effects of Metolazone, Acetazolamide, and a Drug Combination for Patients with Chronic Heart Failure

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Metolazone
    • Acetazolamide
    Italy

  • Study on the Effects of Fluorouracil and Capecitabine in Patients with Metastatic Colorectal Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Capecitabine
    • Fluorouracil
    Finland

  • Study on the Safety and Effects of VERT-002 for Patients with Advanced Solid Tumors, Including Lung Cancer with MET Alterations

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • VERT-002
    Belgium France Germany Italy The Netherlands Spain
Previous Page
1 … 268 269 270 271 272 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!